BWXT Names Heatherly H. Dukes President of BWXT Technical Services Group, Inc.
BWX Technologies, Inc. announced today that Heatherly H. Dukes has been named president of BWXT Technical Services Group, Inc. (TSG).
BWXT to Participate in Seaport Global Energy and Industrials Conference
BWX Technologies, Inc. (NYSE:BWXT) announced today that Senior Vice President and Chief Financial Officer David Black will be participating in the Seaport Global Energy and Industrials Conference in Chicago on August 28, 2018.
BWXT Names Gerhard Burbach to Board of Directors
BWX Technologies, Inc. (NYSE:BWXT) announced today that Gerhard “Gary” F. Burbach has been appointed to its board of directors.
BWXT Completes Acquisition of Sotera Health’s Nordion Medical Isotope Business
BWX Technologies, Inc. announced today that it has completed the acquisition of Sotera Health’s Nordion medical isotope business.
BWXT Names Thomas E. McCabe as Senior Vice President and General Counsel
BWX Technologies, Inc. (NYSE:BWXT) announced today that Thomas (Tom) E. McCabe has been named senior vice president, general counsel, chief compliance officer and corporate secretary for BWXT effective July 23, 2018.
BWXT Signs Medical Isotope Development Agreement with Bruce Power
(LYNCHBURG, Va. – July 12, 2018) – BWX Technologies, Inc. (NYSE:BWXT) announced today that a subsidiary has signed an agreement with Bruce Power that will enable the two companies to collaborate on the development and supply of medical isotopes.
BWXT Names John A. Stewart President of Nuclear Fuel Services
BWX Technologies, Inc. (NYSE:BWXT) announced today that John A. Stewart has been named president of Nuclear Fuel Services, Inc. (NFS) effective July 1, 2018.
BWXT Selects Ontario Power Generation to Provide Irradiation Services for New Medical Isotope Manufacturing Technology
BWX Technologies, Inc. is expanding its longstanding relationship with Ontario Power Generation (OPG), whose wholly owned subsidiary Canadian Nuclear Partners (CNP) plans to provide irradiation services to support BWXT’s new medical isotope manufacturing technology for molybdenum-99.
BWXT Names Chris E. Rhodes General Manager of Euclid, Ohio Operations
BWX Technologies, Inc. announced today that Chris E. Rhodes has been named general manager of the BWXT Nuclear Operations Group, Inc. (BWXT NOG) manufacturing facility in Euclid, Ohio.